Hoberman Kenneth

Chief Operating Officer at STEMLINE THERAPEUTICS INC

Sold, on record
$5.8M
Dollars the filings state
Form 4 sales
28
Latest Mar 10, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Mar 12, 2019 2019

    Sold 26,082 shares at $11.11 ($290k)

    Hoberman Kenneth, Chief Operating Officer

    Sold 3.3% of holdings ($8.7M position)755,696 shares left2.3x usual sizeFiling

  2. 2 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    May 14, 2019 +63 days

    Sold 25,817 shares at $14.27 ($368k)

    Hoberman Kenneth, Chief Operating Officer

    Sold 3.4% of holdings ($10.8M position)729,879 shares left2.2x usual sizeFiling

  3. 3 Form 4 sale STEMLINE THERAPEUTICS INCUnusual
    Jun 26, 2019 +43 days

    Sold 47,115 shares at $15.07 ($710k)

    Hoberman Kenneth, Chief Operating Officer

    Sold 6.5% of holdings ($11M position)682,764 shares left3.7x usual sizeFiling

  4. 4 Form 4 sale STEMLINE THERAPEUTICS INCUnusual
    Dec 27, 2019 +184 days

    Sold 46,312 shares at $10.84 ($502k)

    Hoberman Kenneth, Chief Operating Officer

    Sold 6.8% of holdings ($7.4M position)636,452 shares left3.4x usual sizeFiling

  5. 5 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Jan 8, 2020 +12 days

    Sold 13,228 shares at $10.37 ($137k)

    Hoberman Kenneth, Chief Operating Officer

    Sold 2.1% of holdings ($6.6M position)623,224 shares left0.9x usual sizeFiling

  6. 6 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Jan 22, 2020 +14 days

    Sold 22,139 shares at $7.02 ($155k)

    Hoberman Kenneth, Chief Operating Officer

    Sold 3.6% of holdings ($4.4M position)601,085 shares left1.6x usual sizeFiling

  7. 7 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Feb 25, 2020 +34 days

    Sold 11,547 shares at $6.42 ($74k)

    Hoberman Kenneth, Chief Operating Officer

    Sold 1.4% of holdings ($5.2M position)797,955 shares left0.5x usual sizeFiling

  8. 8 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Mar 10, 2020 +14 days

    Sold 26,191 shares at $4.97 ($130k)

    Hoberman Kenneth, Chief Operating Officer

    Sold 3.3% of holdings ($4M position)771,764 shares left1.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (28)

Form 144 notices and Form 4 sales by Hoberman Kenneth
Source
Mar 10, 2020Mar 13, 2020STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale26,191$130k3.3%Plan not statedSEC
Feb 25, 2020Feb 28, 2020STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale11,547$74k1.4%Plan not statedSEC
Jan 22, 2020Jan 24, 2020STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale22,139$155k3.6%Plan not statedSEC
Jan 8, 2020Jan 10, 2020STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale13,228$137k2.1%Plan not statedSEC
Dec 27, 2019Jan 3, 2020STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale46,312$502k6.8%UnusualSEC
Jun 26, 2019Jun 28, 2019STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale47,115$710k6.5%UnusualSEC
May 14, 2019May 17, 2019STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale25,817$368k3.4%Plan not statedSEC
Mar 12, 2019Mar 15, 2019STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale26,082$290k3.3%Plan not statedSEC
Mar 7, 2019Mar 8, 2019STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale2,995$34k0.4%Plan not statedSEC
Feb 25, 2019Feb 27, 2019STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale10,557$127k1.3%Plan not statedSEC
Jan 8, 2019Jan 11, 2019STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale13,547$138k2.1%Plan not statedSEC
Nov 26, 2018Nov 30, 2018STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale26,296$312k3.8%UnusualSEC
Mar 13, 2018Mar 14, 2018STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale29,987$514k6.8%UnusualSEC
Mar 7, 2018Mar 9, 2018STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale3,027$50k0.8%Plan not statedSEC
Feb 27, 2018Feb 28, 2018STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale11,026$192k2.9%Plan not statedSEC
Feb 15, 2018Feb 16, 2018STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale1,851$29k0.5%Plan not statedSEC
Jan 8, 2018Jan 12, 2018STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale14,040$196k3.5%UnusualSEC
Dec 18, 2017Dec 19, 2017STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale11,983$170k2.9%UnusualSEC
Mar 7, 2017Mar 9, 2017STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale2,342$19k0.8%Plan not statedSEC
Feb 28, 2017Mar 1, 2017STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale8,027$56k2.8%UnusualSEC
Feb 16, 2017Feb 17, 2017STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale1,508$10k0.5%Plan not statedSEC
Jan 10, 2017Jan 13, 2017STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale9,110$126k3.1%UnusualSEC
Mar 8, 2016Mar 10, 2016STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale2,412$13k0.8%Plan not statedSEC
Feb 17, 2016Feb 19, 2016STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale1,503$7k0.7%Plan not statedSEC
Mar 19, 2015Mar 20, 2015STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale17,307$284k12.4%Plan not statedSEC
Feb 18, 2015Feb 20, 2015STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale1,593$22k1.8%Plan not statedSEC
May 21, 2014May 23, 2014STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale15,250$203k14.8%Plan not statedSEC
Nov 27, 2013Nov 27, 2013STEMLINE THERAPEUTICS INCChief Operating OfficerForm 4 sale44,428$921k33.6%UnusualSEC